Topical Treatment of Actinic Keratosis

Primary Field-Directed Treatment Options

The American Academy of Dermatology strongly recommends 5-fluorouracil 5% cream as the most effective topical field treatment for actinic keratosis on the forehead, with complete clearance rates of 38-70% and moderate-to-high quality evidence 1, 2
Apply 5% cream twice daily for 2-4 weeks, treating up to 500 cm² maximum surface area due to toxicity considerations, as recommended by the British Journal of Dermatology 1, 3
The American Academy of Dermatology also strongly recommends imiquimod 5% cream as an alternative field treatment, with complete clearance rates of 44-46% at 8 weeks post-treatment 1, 2
Imiquimod 5% cream should be applied 3 times per week for 4 weeks, which can be repeated for another 4 weeks if needed, according to the British Journal of Dermatology 4

Complete clearance rates of 38% at 6 months and up to 70-78% with optimal regimens can be expected with 5-fluorouracil 5% cream, as reported by the Journal of the American Academy of Dermatology 1, 3
Over 90% of patients experience irritation with 0.5% formulations, and patients should be counseled to expect soreness, redness, and crusting, as noted by the Journal of the American Academy of Dermatology 1 and the British Journal of Dermatology 3

Imiquimod 3.75% cream provides moderate efficacy with lower side-effect profile, applied daily for 2-week cycles, achieving 34-36% complete clearance, as recommended by the Journal of the American Academy of Dermatology 1 and the British Journal of Dermatology 3
Diclofenac 3% gel has moderate efficacy with low morbidity for mild actinic keratoses, applied twice daily for 60-90 days, achieving 50-70% target lesion clearance, according to the British Journal of Dermatology 5, 6

The combination of 5-fluorouracil and calcipotriol demonstrates superior results, with 87.8% mean reduction in facial AK count versus 26.3% with 5-FU alone, as reported by the Journal of the American Academy of Dermatology 1, 2

ALA-red light PDT is conditionally recommended with 77.1% complete clearance at 12 weeks, and ALA-blue light PDT is also conditionally recommended with moderate quality evidence, as noted by the Journal of the American Academy of Dermatology 1 and Praxis Medical Insights 7

Start with a small test area to establish tolerance before treating the entire forehead, especially with 5-FU or imiquimod, as recommended by the British Journal of Dermatology 3
Recurrence rates are high, up to 50% within the first year, necessitating ongoing monitoring and potential retreatment, as reported by Praxis Medical Insights 7
UV protection is mandatory for all patients with actinic keratoses to prevent new lesion development, as noted by Praxis Medical Insights 7 and the British Journal of Dermatology 5